{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T10:42:11Z","timestamp":1707734531419},"reference-count":39,"publisher":"Cambridge University Press (CUP)","issue":"1","license":[{"start":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T00:00:00Z","timestamp":1561680000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":["cambridge.org"],"crossmark-restriction":true},"short-container-title":["Br J Nutr"],"published-print":{"date-parts":[[2019,7,14]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>No risk assessment tools for the efficacy of folic acid treatment for hyperhomocysteinaemia (HHcy) have been developed. We aimed to use two common genetic risk score (GRS) methods to construct prediction models for the efficacy of folic acid therapy on HHcy, and the best gene\u2013environment prediction model was screened out. A prospective cohort study enrolling 638 HHcy patients was performed. We used a logistic regression model to estimate the associations of two GRS methods with the efficacy. Performances were compared using area under the receiver operating characteristic curve (AUC). The simple count genetic risk score (SC-GRS) and weighted genetic risk score (wGRS) were found to be independently associated with the efficacy of folic acid treatment for HHcy. Using the SC-GRS, per risk allele increased with a 1\u00b746-fold increased failure risk (<jats:italic>P<\/jats:italic> &lt; 0\u00b7001) after adjustment for traditional risk factors, including age, sex, BMI, smoking, alcohol consumption, history of diabetes, history of hypertension, history of hyperlipidaemia, history of stroke and history of CHD. When used the wGRS, the association was strengthened (OR = 2\u00b708, <jats:italic>P<\/jats:italic> &lt; 0\u00b7001). Addition of the SC-GRS and wGRS to the traditional risk model significantly improved the predictive ability by AUC (0\u00b7859). A precise gene\u2013environment predictive model with good performance was developed for predicting the treatment failure rate of folic acid therapy for HHcy.<\/jats:p>","DOI":"10.1017\/s0007114519000783","type":"journal-article","created":{"date-parts":[[2019,4,2]],"date-time":"2019-04-02T04:44:14Z","timestamp":1554180254000},"page":"39-46","update-policy":"http:\/\/dx.doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":3,"title":["Prediction model for the efficacy of folic acid therapy on hyperhomocysteinaemia based on genetic risk score methods"],"prefix":"10.1017","volume":"122","author":[{"given":"Binghui","family":"Du","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengda","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Limin","family":"Yue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bingnan","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinglin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dankang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanhong","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weidong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2019,6,28]]},"reference":[{"key":"S0007114519000783_ref5","doi-asserted-by":"publisher","DOI":"10.1631\/jzus.B1400183"},{"key":"S0007114519000783_ref28","doi-asserted-by":"publisher","DOI":"10.5539\/gjhs.v8n7p41"},{"key":"S0007114519000783_ref37","doi-asserted-by":"publisher","DOI":"10.1097\/PRS.0000000000005208"},{"key":"S0007114519000783_ref21","first-page":"969","article-title":"A genetic risk score for hypertension associates with the risk of ischemic stroke in a Swedish case\u2013control study.","volume":"23","author":"Fava","year":"2015","journal-title":"Hum Genet"},{"key":"S0007114519000783_ref32","doi-asserted-by":"publisher","DOI":"10.1038\/jhg.2016.93"},{"key":"S0007114519000783_ref34","unstructured":"34. Che R & Motsinger-Reif AA (2012) A new explained-variance based genetic risk score for predictive modeling of disease risk. Stat Appl Genet Mol Biol 11, article 15."},{"key":"S0007114519000783_ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s00774-018-0920-5"},{"key":"S0007114519000783_ref36","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/eurheartj\/ehv462","article-title":"Risk prediction by genetic risk scores for coronary heart disease is independent of self-reported family history","volume":"37","author":"Hayato","year":"2016","journal-title":"Eur Heart J"},{"key":"S0007114519000783_ref16","doi-asserted-by":"publisher","DOI":"10.1080\/07315724.2017.1330162"},{"key":"S0007114519000783_ref13","doi-asserted-by":"publisher","DOI":"10.4162\/nrp.2017.11.4.327"},{"key":"S0007114519000783_ref8","first-page":"S59","article-title":"Lowering blood homocysteine with folic acid-based supplements: meta-analysis of randomised trials","volume":"52","author":"Clarke","year":"2000","journal-title":"Indian Heart J"},{"key":"S0007114519000783_ref30","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204133"},{"key":"S0007114519000783_ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2004.08.004"},{"key":"S0007114519000783_ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s11883-007-0048-x"},{"key":"S0007114519000783_ref27","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.17.6.1157"},{"key":"S0007114519000783_ref20","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b4838"},{"key":"S0007114519000783_ref2","doi-asserted-by":"publisher","DOI":"10.3390\/nu8100645"},{"key":"S0007114519000783_ref25","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.117.310211"},{"key":"S0007114519000783_ref6","first-page":"121","article-title":"Factors associated with Alzheimer\u2019s disease: an overview of reviews","volume":"6","author":"Rochoy","year":"2019","journal-title":"J Prev Alzheimers Dis"},{"key":"S0007114519000783_ref7","doi-asserted-by":"publisher","DOI":"10.3945\/ajcn.114.090043"},{"key":"S0007114519000783_ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.reprotox.2017.07.001"},{"key":"S0007114519000783_ref17","doi-asserted-by":"publisher","DOI":"10.1017\/S0007114518000508"},{"key":"S0007114519000783_ref12","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwq197"},{"key":"S0007114519000783_ref14","doi-asserted-by":"publisher","DOI":"10.3390\/nu5051531"},{"key":"S0007114519000783_ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2014.09.032"},{"key":"S0007114519000783_ref26","doi-asserted-by":"publisher","DOI":"10.1006\/mgme.2000.2993"},{"key":"S0007114519000783_ref29","doi-asserted-by":"publisher","DOI":"10.1002\/sim.2929"},{"key":"S0007114519000783_ref31","doi-asserted-by":"publisher","DOI":"10.1007\/s00439-017-1816-5"},{"key":"S0007114519000783_ref33","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-017-0888-4"},{"key":"S0007114519000783_ref11","first-page":"S195","article-title":"Effect of folic acid supplementation on plasma homocysteine in obese children: a randomized, double-blind, placebo-controlled trial","volume":"97","author":"Iamopas","year":"2014","journal-title":"J Med Assoc Thailand"},{"key":"S0007114519000783_ref18","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2891-11-2"},{"key":"S0007114519000783_ref19","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v22.i14.3777"},{"key":"S0007114519000783_ref38","doi-asserted-by":"crossref","first-page":"520","DOI":"10.4103\/1008-682X.179527","article-title":"Population-standardized genetic risk score: the SNP-based method of choice for inherited risk assessment of prostate cancer","volume":"18","author":"Conran","year":"2016","journal-title":"Asian J Androl"},{"key":"S0007114519000783_ref39","doi-asserted-by":"publisher","DOI":"10.2337\/dc13-1514"},{"key":"S0007114519000783_ref35","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.116.014506"},{"key":"S0007114519000783_ref15","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000002652"},{"key":"S0007114519000783_ref4","doi-asserted-by":"publisher","DOI":"10.1089\/dna.2017.3845"},{"key":"S0007114519000783_ref10","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ejcn.1602351"},{"key":"S0007114519000783_ref22","doi-asserted-by":"publisher","DOI":"10.1002\/sim.4006"}],"container-title":["British Journal of Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0007114519000783","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,12]],"date-time":"2019-08-12T06:36:41Z","timestamp":1565591801000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0007114519000783\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,28]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,7,14]]}},"alternative-id":["S0007114519000783"],"URL":"https:\/\/doi.org\/10.1017\/s0007114519000783","relation":{},"ISSN":["0007-1145","1475-2662"],"issn-type":[{"value":"0007-1145","type":"print"},{"value":"1475-2662","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,28]]},"assertion":[{"value":"\u00a9 The Authors 2019\u00a0","name":"copyright","label":"Copyright","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}}]}}